Umberto Nencha

Dr. Umberto Nencha

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2025 in The Lancet Healthy Longevity
Verified
Journal Article
Open access
AMAugusto J. Mendes
Augusto J. Mendes
FRFederica Ribaldi
Federica Ribaldi
OSOzge Sayin
Ozge Sayin
GKGiorgi Khachvani
Giorgi Khachvani
RMRoberta Mulargia
Roberta Mulargia
GFGiovanni B Frisoni
Giovanni B Frisoni
Preventing cognitive impairment in older adults is a public health priority. Although multidomain interventions have shown promise as preventive strategies, the optimal combination of interventions remains unclear. This network meta-analysis aimed to compare and rank the relative efficacy of single-domain and multidomain lifestyle interventions for the prevention of cognitive impairment in older adults who are cognitively unimpaired. We did a systematic review and network meta-analysis of randomised controlled trials (RCTs) published in PubMed and Embase from inception until the date of our search on May 7, 2024 following a preregistered protocol in PROSPERO (CRD42024601975). We included RCTs in older adults who are cognitively unimpaired evaluating lifestyle interventions targeting diet, physical exercise, cognitive training, social activity, and health education, either alone or in combination. The primary outcome was global cognition, analysed using random-effects network meta-analysis, reporting standardised mean differences (SMDs) and 95% CIs, and compared against health education, active control, or no intervention. Subgroup analyses explored potential age-related differences and the effect of intervention duration. Risk of bias was assessed using Cochrane Risk of Bias 2, and publication bias was evaluated by assessing funnel plot asymmetry. Of the 10 200 citations identified and 1183 full texts screened for eligibility, we identified 109 eligible RCTs, including 23 010 participants (median age 70·1 years [IQR 68·7-73·8], 14 957 [65%] female and 8053 [35%] male). Compared with health education, significant improvements in global cognition were found for physical exercise and cognitive training combined (SMD 0·26 [95% CI 0·10-0·42; p=0·0011); cognitive training alone (SMD 0·21 [0·08-0·33]; p=0·00092); diet, physical exercise, cognitive training, and health education combined (SMD 0·14 [0·02-0·27]; p=0·028); and physical exercise alone (SMD 0·14 [0·05-0·22]; p=0·0014). Random-effects models using active control and no intervention as comparators yielded similarly significant effects for the aforementioned interventions, with effect sizes in the same order. Risk of bias was high in 44 (40%) studies, and publication bias was suggested in studies comparing interventions with health education. Several single-domain and multidomain lifestyle interventions are efficacious at modulating global cognition in older adults who are cognitively unimpaired, with the combination of physical exercise and cognitive training demonstrating the strongest effect. Combining lifestyle interventions might enhance efficacy, but increased number of domains does not automatically translate into greater cognitive benefits. These findings support lifestyle interventions as key components of prevention strategies; however, their optimal combination requires further investigation. None.

Verified
Journal Article
Open access
PDF file
AAAlice Accorroni
Alice Accorroni
UNUmberto Nencha
Umberto Nencha
IBIndrit Bègue
Indrit Bègue
The study of brain disorders has long been central to both neurology and psychiatry, with these two disciplines evolving as distinct yet deeply interconnected fields. In fact, these specialties often share overlapping symptoms, neural pathways, and treatment modalities, making interdisciplinary collaboration essential. Despite this, such collaborations remain sparse, particularly in clinical settings, research, training, and policy development. The increasing global burden of brain disorders has induced a paradigm shift, emphasizing the need for cooperative efforts to preserve brain health. Effective interdisciplinary collaborations between neurology and psychiatry as well as with other partners involved in brain health and other medical specialties is crucial to improving patient outcomes and societal well-being. Furthermore, the development of comprehensive training programs in brain health is vital, aligning with the recent rise in brain medicine as a unified field. This article reviews the historical evolution of neurology and psychiatry, explores current synergies, and identifies areas for future collaboration, particularly in enhancing research, education, and shared preventative strategies. Ultimately, fostering interdisciplinary collaboration between neurology and psychiatry along with other medical specialties and relevant partners will be key to advancing brain health and addressing the global burden of brain disorders.

3 March 2023 in Medicina
Verified
Journal Article
Open access
PDF file
ESEglė Sukockienė
Eglė Sukockienė
GBGautier Breville
Gautier Breville
DFDamien Fayolle
Damien Fayolle
UNUmberto Nencha
Umberto Nencha
MUMarjolaine Uginet
Marjolaine Uginet
AHAnnemarie Hübers
Annemarie Hübers
Background and Objectives: Vaccination has been critical to managing the COVID-19 pandemic. Autoimmunity of the nervous system, especially among a select set of high-risk groups, can be triggered or enhanced by the contents of vaccines. Here, we report a case series of acute peripheral neuropathies following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report on 11 patients (range: 30–90 years old) who presented at our center between January 2021 and February 2022. Methods: We obtained the patients’ history and performed clinical neurological examination and electromyoneurography on all subjects. If necessary, magnetic resonance imaging and laboratory testing, including cerebrospinal fluid analysis and specific antibody testing, were performed. Results: Patients presented with peripheral neuropathies of acute onset between 1 and 40 days after vaccination with different types of COVID-19 vaccines. Most cases (9/11) resolved with a rapid, complete or partial recovery. Conclusions: We found acute peripheral neuropathies in a set of individuals after they received vaccines against SARS-CoV-2. Albeit our observation shows that during extensive vaccination programs, negative side effects on the peripheral nervous system might occur, most of them showed benign clinical evolution. Thus, potential side effects should not hinder the prescription of vaccines. More extensive studies are needed to elucidate populations at risk of developing peripheral neuropathies and mechanisms of autoimmune response in the nervous system.

30 March 2024 in Neurobiology of Aging
Verified
Journal Article
Open access
UNUmberto Nencha
Umberto Nencha
IRIsotta Rigoni
Isotta Rigoni
FRFederica Ribaldi
Federica Ribaldi
DADaniele Altomare
Daniele Altomare
MSMargitta Seeck
Margitta Seeck
GFGiovanni B. Frisoni
Giovanni B. Frisoni
We assessed the relationship of gamma oscillations with tau deposition in Alzheimer 's disease (AD) and other cognitive diseases, as both are altered during the disease course and relate to neurodegeneration. We retrospectively analyzed data from 7 AD, tau positive patients and 9 tau negative patients, who underwent cerebral amyloid PET and tau PET, and EEG within 12 months. Relative gamma power was higher in tau positive (AD) patients than in tau negative patients (p < .05). In tau positive AD patients, tau burden was associated with a linear increase in gamma power (p < .05), while no association was present in the tau negative group nor with amyloid- beta burden in either group. Thus, increase in the gamma power might represent a novel biomarker for tau driven neurodegeneration.

Verified
Journal Article
Open access
PDF file
AAAlice Accorroni
Alice Accorroni
DZDavide Zani
Davide Zani
IPIliya Petkov Peyneshki
Iliya Petkov Peyneshki
UNUmberto Nencha
Umberto Nencha
Valentina BasileValentina Basile
Valentina Basile
VCViolette Marie Corre
Violette Marie Corre
The concept of Brain Health is transforming the neuroscientific landscape, promoting an integrative and preventive approach to care under a unifying vision. This position paper, developed by Swiss junior societies in neurology and psychiatry, presents a trainee perspective on how Brain Health should be addressed from the earliest stages of postgraduate training. It explores current gaps in postgraduate training, including the continued separation of neurology, psychiatry and other specialties involved in brain disorder care, limited interdisciplinary and interprofessional exposure, and gaps in leadership, public health, and advocacy skills. We highlight promising models such as Switzerland’s integrated training components and the proposed “brain medicine” framework, inspired by internal medicine. Additionally, we examine innovative initiatives from trainee associations that promote collaborative learning, advocacy, and Brain Health awareness through academic and creative channels. The paper also stresses the importance of equitable global access to training, the integration of research into clinical education, and the urgent need to address burnout and working conditions among early-career professionals. By reframing trainees not as passive learners but as active agents of change, we call for systemic reforms that support their role in advancing Brain Health. Ultimately, we advocate for the development of international core competencies, adaptable curricula, and structured interdisciplinary pathways that embed Brain Health into every level of medical training. Only through this comprehensive approach can we equip the next generation of clinicians to promote lifelong Brain Health across specialties, systems, and populations.

Verified
Journal Article
Open access
PDF file
RMRoberta Mulargia
Roberta Mulargia
FRFederica Ribaldi
Federica Ribaldi
SMSophie Mutel
Sophie Mutel
OSOzge Sayin
Ozge Sayin
GKGiorgi Khachvani
Giorgi Khachvani
AMAugusto J. Mendes
Augusto J. Mendes
Dementia prevention is a global public health priority, and lifestyle interventions, including nutrition, have gained interest for their potential to maintain cognitive health. Among nutritional interventions, omega-3 polyunsaturated fatty acids (n-3 FA), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been widely studied for their potential to support cognitive health. This systematic review evaluated whether n-3 FA supplementation improves global cognition in cognitively unimpaired older adults. Nineteen randomized controlled trials (RCTs) met inclusion criteria, of which five reported significant improvements in global cognition. A random-effects meta-analysis of 11 placebo-controlled RCTs showed no significant effect (SMD = −0.02, 95% CI: −0.07 to 0.04). Heterogeneity in supplement type, dosage, duration, and outcome measures may have contributed to inconsistent findings and limited comparability. Furthermore, methodological quality of the trials was generally low. While current evidence does not demonstrate a significant effect of n-3 FA supplementation on global cognition, future research should prioritize well-powered, longer-duration RCTs that incorporate biomarker monitoring and more appropriate doses. Clarifying the role of n-3 FA in cognitive aging remains essential for informing nutrition-based dementia prevention strategies.